[Eseroline and hypophyseal-adrenocortical reactivity].
B
B
Loscalzo
A
A
Agrusta
M
M
Agrusta
A
A
Crisci
L
L
Genovese
M
M
Marino
D000302:Adrenal Cortex / Q000737:chemistry / Q000378:metabolism*; D000701:Analgesics, Opioid / Q000008:administration & dosage / Q000494:pharmacology*; D000818:Animals; D001205:Ascorbic Acid / Q000032:analysis; D002784:Cholesterol / Q000032:analysis; D003345:Corticosterone / Q000097:blood / Q000378:metabolism*; D004305:Dose-Response Relationship, Drug; D005260:Female; D007211:Indoles / Q000008:administration & dosage / Q000494:pharmacology*; D007274:Injections, Intraperitoneal; D008297:Male; D010913:Pituitary-Adrenal System / Q000187:drug effects*; D051381:Rats
D000701:Analgesics, Opioid; D007211:Indoles; D002784:Cholesterol; D001205:Ascorbic Acid; C022594:eseroline; D003345:Corticosterone